Invesco Ltd. - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 40 filers reported holding SINOVAC BIOTECH LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q3 2018$619,000
+296.8%
81,265
+288.4%
0.00%
Q2 2018$156,000
-83.1%
20,923
-80.5%
0.00%
Q1 2018$923,000
+24.4%
107,171
-2.5%
0.00%
Q2 2017$742,000
+30.6%
109,967
+11.0%
0.00%
Q1 2017$568,000
-3.2%
99,086
-0.4%
0.00%
Q4 2016$587,000
-12.8%
99,509
-12.8%
0.00%
Q3 2016$673,000
-0.4%
114,088
+0.0%
0.00%
Q2 2016$676,000
-0.1%
114,045
+7.6%
0.00%
Q1 2016$677,000
+11.0%
105,964
-0.7%
0.00%
Q4 2015$610,000
+35.9%
106,661
+20.6%
0.00%
Q3 2015$449,000
-12.0%
88,450
-9.0%
0.00%
Q2 2015$510,000
-11.8%
97,161
-16.6%
0.00%
Q1 2015$578,000
-23.1%
116,542
-18.9%
0.00%
Q4 2014$752,000
-22.2%
143,732
-28.5%
0.00%
Q3 2014$967,000
-1.6%
201,135
+15.4%
0.00%
Q2 2014$983,000
-24.3%
174,255
-3.4%
0.00%
-100.0%
Q1 2014$1,299,000
-7.6%
180,452
-21.5%
0.00%0.0%
Q4 2013$1,406,000
-1.7%
229,748
-3.9%
0.00%0.0%
Q3 2013$1,430,000
+75.5%
239,166
+15.3%
0.00%
Q2 2013$815,000207,4880.00%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q1 2015
NameSharesValueWeighting ↓
Orbimed Advisors 2,718,735$340,000,0007.22%
Vivo Capital, LLC 5,900,000$38,173,0004.18%
Neumann Advisory Hong Kong Ltd 315,586$2,0420.82%
Financial Gravity Asset Management, Inc. 988$3,197,6860.04%
Yorktown Management & Research Co Inc 149,786$4,4940.01%
Renaissance Technologies 2,375,841$1,5370.00%
WELLS FARGO & COMPANY/MN 1,661$10,7470.00%
NORTHERN TRUST CORP 13,787$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 412$2,6660.00%
View complete list of SINOVAC BIOTECH LTD shareholders